Gilliland Jeter Wealth Management LLC raised its stake in shares of Counterpoint Quantitative Equity ETF (NYSE:CPAI – Free Report) by 42.4% in the third quarter, Holdings Channel.com reports. The fund owned 40,874 shares of the company’s stock after purchasing an additional 12,167 shares during the period. Gilliland Jeter Wealth Management LLC’s holdings in Counterpoint Quantitative Equity ETF were worth $2,113,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the company. NewEdge Advisors LLC increased its stake in Counterpoint Quantitative Equity ETF by 230.6% during the 2nd quarter. NewEdge Advisors LLC now owns 111,269 shares of the company’s stock worth $5,782,000 after buying an additional 77,610 shares during the period. Counterpoint Mutual Funds LLC lifted its holdings in Counterpoint Quantitative Equity ETF by 5.3% during the 1st quarter. Counterpoint Mutual Funds LLC now owns 1,549,616 shares of the company’s stock worth $64,758,000 after buying an additional 78,500 shares during the last quarter. Royal Bank of Canada lifted its stake in Counterpoint Quantitative Equity ETF by 122.6% during the first quarter. Royal Bank of Canada now owns 44,196 shares of the company’s stock worth $1,847,000 after purchasing an additional 24,338 shares during the last quarter. Independent Financial Group LLC purchased a new stake in Counterpoint Quantitative Equity ETF in the first quarter valued at $3,154,000. Finally, Hilltop Holdings Inc. acquired a new stake in shares of Counterpoint Quantitative Equity ETF in the 1st quarter valued at about $459,000.
Counterpoint Quantitative Equity ETF Trading Down 2.1%
Shares of CPAI opened at $52.58 on Friday. Counterpoint Quantitative Equity ETF has a 12-month low of $37.29 and a 12-month high of $53.96. The company’s 50 day simple moving average is $52.43 and its 200-day simple moving average is $48.37. The firm has a market cap of $525.27 million, a PE ratio of -63,045.56 and a beta of 1.18.
Counterpoint Quantitative Equity ETF Profile
The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.
See Also
- Five stocks we like better than Counterpoint Quantitative Equity ETF
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Want to see what other hedge funds are holding CPAI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Counterpoint Quantitative Equity ETF (NYSE:CPAI – Free Report).
Receive News & Ratings for Counterpoint Quantitative Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Counterpoint Quantitative Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
